<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>paper on blog.med.schu.im</title><link>https://blog.med.schu.im/tags/paper/</link><description>Recent content in paper on blog.med.schu.im</description><generator>Hugo -- gohugo.io</generator><language>en</language><lastBuildDate>Thu, 27 Oct 2022 18:40:16 +0200</lastBuildDate><atom:link href="https://blog.med.schu.im/tags/paper/index.xml" rel="self" type="application/rss+xml"/><item><title>Paper: Epidemiology, management, and outcome of infection, sepsis, and septic shock in a German emergency department (EpiSEP study)</title><link>https://blog.med.schu.im/epidemiology-management-and-outcome-of-infection-sepsis-and-septic-shock-in-a-german-emergency-department/</link><pubDate>Thu, 27 Oct 2022 18:40:16 +0200</pubDate><guid>https://blog.med.schu.im/epidemiology-management-and-outcome-of-infection-sepsis-and-septic-shock-in-a-german-emergency-department/</guid><description>Frontiers in Medicine: https://www.frontiersin.org/articles/10.3389/fmed.2022.997992/full</description></item><item><title>Paper: Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge</title><link>https://blog.med.schu.im/nirmatrelvir-use-and-severe-covid-19-outcomes-during-omicron-surge/</link><pubDate>Tue, 20 Sep 2022 10:06:23 +0200</pubDate><guid>https://blog.med.schu.im/nirmatrelvir-use-and-severe-covid-19-outcomes-during-omicron-surge/</guid><description>PubMed: https://pubmed.ncbi.nlm.nih.gov/36001529/</description></item></channel></rss>